Hey guys, I run upon $PAVS (PAVmed) and the valuation looks absurd.
They own a massive stake in Lucid Diagnostics ($LUCD) and their own AI oncology platform Veris. If you value these assets separately, $PAVS should be worth at least $20M-$25M.
Float is around 3.2M shares and it has a 24.4% SI. That's 770k shares that need to be covered in a very thin order book. I'm seeing a massive gap between $1.80 and $3.50. Thoughts on this?